Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD

Clinical trial NCT06110130 · RECRUITING

Trial details

NCT number: NCT06110130
Sponsor: Washington D.C. Veterans Affairs Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Kidney Diseases

Start date: 2024-02-02
Primary completion: 2027-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.